Team

At InnoMedica, experienced entrepreneurs and managers work side-by-side with university graduates. InnoMedica’s goal is to involve the entire team as shareholders and to develop an entrepreneurial spirit among its employees. Today the InnoMedica team consists of 22 employees – all with higher education, whereby the strong technical focus of InnoMedica is reflected in the 14 employees with degrees in biochemistry, chemistry or medicine. The high level of expertise in this core area is an important requirement for our success.

 

Organigramm

Peter Halbherr
Peter Halbherr
Dr. phil. et phil. Universites of Zürich and Paris

Dr. Peter Halbherr has been with InnoMedica since 2001. He was member of the Board since 2002, acts as delegate of the Board and was elected chairman by the general assembly 2018. As a business and personnel consultant in the pharmaceutical, IT and financial sector, Dr. Halbherr provides expertise in building companies and access to a valuable network of executives, startups and financing.

Dr. Halbherr founded the consulting firm IPAG Inter Personal AG in 1988, which is active in management selection and management consultancy. Under his direction IPAG Inter Personal AG provided the initial funding for InnoMedica and served as incubator for the Talidox project. He is partner of BTS Business Technology & Services GmbH, which is active in software in Business Administration. Dr. Halbherr developed sqlFinance an Enterprise Resource Planning software, which InnoMedica uses today for accounting, payroll, purchasing and delivery/sales as well as for pharmaceutical GMP production.

Dr. Halbherr’s doctoral dissertation on career patterns, a DESS Psychology in Industrial Psychology, was a research project on careers and corporate culture in Paris (1979 – 1983, published as IBM – Mythe et Mythe et Réalité) resulted in a Dr. phil. et phil. degree from the Universities of Zurich and Paris. Previously, he studied psychology and graduated from the University of Zurich.

Chairman and Delegate of the Board, General Manager
Denis Bron
Denis Bron
Dr. med., University of Basel

Dr. med. Denis Bron has operated since 2005 as InnoMedica’s Medical Advisor and joined the Board of InnoMedica in 2018. He brings a broad network in the medical sector as well as experience in dealing with doctors and hospitals. Dr. Bron also holds an earlier patent which he introduced in 2010 into the company based on a targeting approach for pharmaceutical active ingredients.

Dr. Bron is chief of Aviation Medicine for the Air Force of the Aeromedical Institute FAI and directs the Aeromedical Centre (AeMC) in Dübendorf. He previously worked in the field of neurology at Harvard Medical School in Boston, the University Hospital Basel, and the Cantonal hospital in Aarau. Dr. Bron graduated from the University of Basel in 1997 with a degree in medical studies. In addition to his training in the hospital, he holds the certificate of EMG-competence, completed additional leadership courses and graduated in 2013 as a European Human Factor specialist.

Member of the Board, Vice-Chairman
Herbert Früh
Herbert Früh
Dr. sc. nat., ETH Zurich

Dr. Herbert Früh has been with InnoMedica since 2000. He acted as Chairman of the Board from 2002 until 2018. He has many years of experience with industrial standards in the pharmaceutical industry, and is an expert in clinical trials.

In addition to his activity with InnoMedica, Dr. Früh has served as Head of dental start-up Regedent AG. Previously he worked as Regenerative Business Unit Manager at Straumann. He has also held the position of Head of Chemicals, Agrochemicals, and Water Engineering at CU Chemie Uetikon. As the Managing Director of Pharmaceuticals and Biomaterials at Geistlich, he led the family business through restructuring, launching of new products in the biomaterial field, and building an international distribution network. At Schering, he worked as Marketing Manager for Hormone Therapy and Dermatological Products. In Hoffmann-LaRoche, he served as Product Manager for Oncology and Infectious Diseases and was responsible for the introduction of Interferon.

Dr. Früh graduated from ETH Zürich with a degree in biochemistry and microbiology. After receiving his doctorate in protein chemistry and enzymology, he started his career in drug development at Spirig. Additionally he completed an MBA program at the Zürich Graduate School of Business Administration.

Member of the Board
Noboru Yamazaki
Noboru Yamazaki
Dr. rer. nat.

Dr. Noboru Yamazaki was elected at the 2013 Annual General Meeting to the Board of InnoMedica. His years of research experience in the field of active targeting and his solid experience in patent applications are key to the success of the InnoMedica Talidox project.

He founded the company Yamazaki DDS Co., Ltd. to develop new applications with an active targeting drug delivery system. This new technology results from his research while working as group leader of the NanoBio-Medicine Technology Laboratory at the Nanotechnology Research Institute of the National Institute of Advanced Industrial Science and Technology (AIST) in Japan. Dr. Yamazaki worked with scientists from the Chemistry Department of the University of Colorado and the Max Planck Institute of Experimental Medicine and was director of research grants at the International Human Frontier Science Program Organization. After receiving his PhD in Biology from the University of Hamburg and postdoctoral research at Mitsubishi Kasei Institute of Life Sciences, Research Officer of the Industrial Products Research Institute, he began his career at AIST as Head of Materials Design Laboratory.

Member of the Board, Chief Technology Office
Manuel C. Frick
Manuel C. Frick
LL.M. Attorney

Manuel C. Frick was elected by the shareholders of InnoMedica as an additional member of the Board of Directors at the 2017 Annual General Meeting. Mr. Frick is an internationally active lawyer and complements the Board of Directors of InnoMedica with his legal expertise, in particular in contract law, European law, procedural law and intellectual property. He was admitted to the bar of the Canton of Berne in 1992, subsequently obtained a diploma in European law from the University of Lausanne and completed his Master of Law (LL.M) at Duke University Law School Durham in North Carolina in 1995. Manuel Frick is a member of the Small Burger Council of the Burgergemeinde Bern and has been Chairman of the Bank Council of DC Bank Bern since 2013. He is also a member of various other boards of directors.

Member of the Board
Pascal Halbherr
Pascal Halbherr
MSc Biochemistry, University of Bern

Pascal Halbherr, elder son of Dr. Peter Halbherr. Head of Production, began working at InnoMedica in Autumn 2012. His interest in the latest research in biochemistry and his readiness to explore novel concepts led to the launch of the collaboration with Dr. Yamazaki and form the starting point of the Talidox project.

Along with Stéphane Gumy, he developed the GMP production at the Marly Innovation Center and adapted the production processes from pure research to industrial scales. He graduated from the University of Bern with a Bachelor’s degree in Biochemistry and a Master’s degree in Immunology (Thromboxane A2 acts as tonic immunoregulator by preferential disruption of low-avidity CD4+ T cell-dendritic cell interactions).

Manufacturing, Project Leader, Management
Stéfan Halbherr
Stéfan Halbherr
PhD, University of Bern
Research and Development, Management
Jonas Zeller
Jonas Zeller
Dr. rer. oec., University of Bern

Dr. Jonas Zeller joined InnoMedica in 2013 as Head of Finance and Administration. He brings experience in Financial Management, and is a lecturer of Business Valuation at the University of Bern and the Bern-Rochester Executive MBA program.

He obtained a doctorate from the Institute of Financial Management at the University of Bern, where his research examined the interaction between age and economic efficiency of enterprises. Prior to his doctoral thesis, he had a role as an analyst in the Economic Research Department at Credit Suisse in Zürich. His graduate studies were at the University of Bern and the Simon Graduate School of Business at the University of Rochester in New York.

Finance & Administration, Management
Andrea Zurkirchen
Andrea Zurkirchen
lic. phil., University of Zürich

Andrea Zurkirchen became part of the InnoMedica team in summer 2012 due to her consulting role with IPAG Inter Personal AG and the merger with Yamazaki-DDS Co., Ltd. She gained experience in personnel management and administration, as well as communications, marketing and sales, through work with IPAG Inter Personal AG and BTS Business Technology & Services GmbH. As Chief of Staff at InnoMedica, she is responsible for the organisation and legal implementation of the financing rounds, looks after shareholder contacts and is also responsible for external communication in addition to her personnel tasks.

She studied psychology at the University of Zurich, specializing in biopsychology and behavioral therapy. In her thesis she examined the connection between psychological and biological reactions to stress.

Communicationl, HR, Legal & Compliance, Staff
Stèphane Gumy
Stèphane Gumy
Chemist Degree, Fribourg
Qualified Person, Staff
Christian Baumgartner
Christian Baumgartner
Dr. med. et MSc Econ., University of Bern

Dr. Christian Baumgartner, M.D. joined InnoMedica in March 2017. With a background as as a clinical doctor and medical advisor, his experience strengthens our understanding of Medical Affairs and brings a valuable clinical perspective into the company. Christian Baumgartner will be working together with Dr. Markus Jörger, M.D. from the SAKK.

After completing his master’s degree in economics, Christian Baumgartner from 2006-2012 studied medicine at the University of Bern, where he wrote his dissertation on the subject of risk assessment in compulsory health insurance. Following his studies, he gained clinical experience as a surgical assistant in Langenthal. In the spring of 2014, he joined GlaxoSmithKline as a Medical & Regulatory Advisor, where he was responsible for the introduction and medical-scientific supervision of a new antibody treatment for most severe forms of asthma before he moved to Innomedica.

Medical Affairs
Urs Bretscher
Urs Bretscher
lic. oec. publ., University of Zurich

Urs Bretscher is responsible for logistics at InnoMedica since the end of 2013. He worked alongside Dr. Peter Halbherr on various projects prior to his employmen with InnoMedica . He brings with him more than 20 years of experience in a number of different businesses, where he worked as Head of Computer Science at the Swatch Group and Chief Information Officer at the Marlox Group and Selecta, gaining valuable know-how. Together with Dr. Peter Halbherr, he is a partner at the Firm BTS, which is active in the field of business administration software.

Urs Bretscher studied Business Information Science at the University of Zürich and graduated with a degree in Economics and Computer Science in 1989. This was followed by further academic studies in the field of Computer Science, including a Postgraduate Course at the University of Geneva.

Logistics (IT, Purchasing & Processes)
Patrick Buschor
Patrick Buschor
PhD, University of Bern
Clinical Research, Quality Assurance
Andreas König
Andreas König
PhD candidate

Andreas König has been working as an organic chemist at InnoMedica since July 2016, specializing in research and analytics. He brings important know-how to InnoMedica through his experience in organic synthesis methodology and development of best practices. With the construction of a chemical synthesis laboratory, he has already contributed to strengthening the research and development focus of our Glycan technology.

During his master’s thesis at the University of Bern under of Prof. Philippe Renaud he developed an efficient method for the hydroazidation of double bonds. He then gained his first experiences outside the university environment with Dr. Alexandar Stojanovic at the Novartis Institute for Biomedical Research in the field of organic synthesis of pharmaceuticals. He then signed up for a Ph.D at the University of Friborg under the supervision of Prof. Christian Bochet, where he wrote his doctoral thesis titled “Flow photochemistry and effords towards the synthesis of the whiskey lactone.”

Chemical Synthesis & Analytics
Christoph Mathieu
Christoph Mathieu
PhD, University of Bern

Dr. Christoph Mathieu joined InnoMedica in August 2015 and is responsible for analytical method and equipment development and validation. Additionally the implementation of GMP guidelines, processes, and reporting are within his sphere of responsibility.

During his Master’s thesis at the Department of Clinical Research in Bern, Christoph gained experience in the quantification of drug residues in waste water by gas chromatography mass spectrometry. His experience working with HPLC has allowed InnoMedica to make rapid progress in the development of its own analysis processes. In 2013, he completed his doctoral thesis on the functional characterization of transport proteins in parasites at the Institute of Plant Sciences at the University of Bern. More recently, he worked in the laboratory of the Department of Anesthesiology and Pain Management at the University Hospital in Bern on Clinical Trials and Research projects.

Quality Control & Analytics
Roman Odermatt
Roman Odermatt
B. A., HSG

Roman Odermatt has worked since September 2015 in Finance and Administration at InnoMedica. He brings experience from his background in Accounting and Trust Law as well as journalistic skills. For his Master’s thesis at the University of Bern, he studied   start-up companies and Venture Capitalists. In the summer of 2016, he completed his studies of business economics and is now working full-time for InnoMedica. Since September 2016, he has been responsible for Talidox product management, which is gaining in importance given the up-coming clinical trial. Prior to joining InnoMedica, he gained work experience in the personnel department at Credit Suisse.

Product Management, Accounting & Financial Analysis
Camille Peitsch
Camille Peitsch
PhD, University of Bern

Dr. Camille Peitsch has been working at InnoMedica in research and development since February 2017. She explores the structure and mechanisms in action of InnoMedica’s liposomes and, together with Stéfan Halbherr, develops further applications of the targeting technology. As a molecular biologist, she brings experience in the visualization of nanostructures and cellular transport mechanisms as well as in development and implementation of best practices to InnoMedica.

In 2012, Camille Peitsch completed Master’s Degree in Molecular Biology at the University of Basel. She completed her doctorate under the supervision of  Prof. Benoît Zuber, titled “Cutting Edge Electron Microscopy for Calcium-Dependent Exocytosis and Trypanosome Morphology Studies,” at the Institute of Anatomy of the University of Bern and had her Doctoral defense in the middle of March 2017. During her doctoral studies, she developed a method enabling isolation from the cell periphery using cryo-electron microscopy.

Research & Development
Florian Weiss
Florian Weiss
PhD, University Basel

Dr. Florian Weiss has been working as a Pharmaceutical Process Engineer for InnoMedica since October 2016. His systematic approach to optimizing manufacturing processes ensures Talidox’s the manufacturing process are well prepared for the clinical trials, and as well he determines the framework and conditions for pharmaceutical production.

Florian Weiss completed his Bachelor’s degree in chemistry and molecular sciences at the University of Bern, where he also finished his master’s degree in Physical Chemistry and Materials Science under the supervision of Prof. Jürg Hulliger. He received his doctorate from the University of Basel, where he wrote his thesis on “Fabrication and Characterization of Nanometers Thin Films for LowVoltage DEAs”, where he was responsible for Empa projects (interdisciplinary research institute of the ETH- Department for Materials Science and Technology) and projects of the Research Center Jülich (DE). He then continued his studies as a PostDoc at the University of Basel contributing to projects in the field of dental implants.

Process Engineering & Production
Philipp Halbherr
Philipp Halbherr
Dr. oec., University of Zurich
Financial Advisor